Cost of products was $30,700,000 compared to $24,300,000 in the Q4 of 2022 with the increase primarily attributable to costs associated with the increased product revenues of $35,900,000 in the 4th quarter, compared to product revenues of $30,000,000 in the Q4 of 2022. Net loss was $7,300,000 or net loss per diluted share of 0 point diluted share of 0.03 in the Q4 of 2022. The $5,000,000 increase in net loss was attributable to firstly, a $3,000,000 negative change in the fair value of our warrant liabilities secondly, a $1,800,000 decrease in interest expense offset by the one time $5,400,000 deleveraging fee payable to our lenders required under the 1st lien term facility due to our lower net debt leverage ratio at year end. And thirdly, a $2,100,000 long lived asset impairment charge I referenced earlier, partially offset by the $4,000,000 positive change in income from operations prior to that long lived asset impairment. As you know, the change in fair value of the annualized loans during the 3 months was a loss of $10,800,000 compared to a loss of $7,800,000 during the 3 months ended December 31, 2022.